Isolated Locoregional Recurrence in Patients with Postmastectomy Adjuvant Therapy for Breast Cancer
نویسندگان
چکیده
Objectives: To determine the predictive risk factors for isolated locoregional recurrence (LRR) in breast cancer patients with postmastectomy adjuvant therapy. Patients and Methods: The impacts of patients’ characteristics, tumor stage, and surgery on LRR were evaluated in patients with breast cancer having postmastectomy adjuvant therapy, according to their risk factors using univariate analysis. Factors influencing LRR-free survival were assessed by Cox regression analysis. Results: Of 368 patients, 28 (7.6%) had isolated LRR. Patients’ characteristics such as age, menopause, surgery, tumor size, stage and differentiation, and hormone receptor status were not attributable to LRR. Upper outer quadrant localization was significantly associated with lower LRR occurrence (p=0.048). Among 245 patients whose surgical margin could be assessed, LRR was detected in 6 (20%) of 30 patients with a close surgical margin, while of 215 patients with normal surgical margin, 13 (6%) developed LRR (p=0.007). Kaplan-Meier analysis revealed that larger tumor (p=0.04), presence of LRR (p=0.00001), closer surgical margin (p=0.0085), stage (p=0.0001), and presence of lymph node metastases (p=0.00001) have significantly negative impacts on patients’ survival. Tumor size, lymph node status, and closer surgical margin were found to be the independent factors influencing LRR-free overall survival. Conclusion: Postmastectomy LRR seemed to have a close relationship with the surgical margin status despite standard adjuvant treatments.
منابع مشابه
Postmastectomy locoregional recurrence and recurrence-free survival in breast cancer patients
BACKGROUND One essential outcome after breast cancer treatment is recurrence of the disease. Treatment decision is based on assessment of prognostic factors of breast cancer recurrence. This study was to investigate the prognostic factors for postmastectomy locoregional recurrence (LRR) and survival in those patients. METHODS 114 patients undergoing mastectomy and adjuvant radiotherapy in Can...
متن کاملPostmastectomy radiation in breast cancer with one to three involved lymph nodes: ending the debate
Many trials in breast cancer have investigated various aspects of locoregional and systemic treatments. Combination of the results of these trials in a meticulous meta-analysis, as has been done several times by the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), fi lls the gaps in evidence and knowledge by conclusively showing signifi cant trends and diff erences. Following public...
متن کاملPostoperative radiotherapy in high-risk postmenopausal breast cancer.
BACKGROUND Postmastectomy radiotherapy is associated with a lower locoregional recurrence rate and improved disease-free and overall survival when combined with chemotherapy in premenopausal high-risk breast-cancer patients. However, whether the same benefits apply also in postmenopausal women treated with adjuvant tamoxifen for similar high-risk cancer is unclear. In a randomised trial among p...
متن کاملComparison of Treatment Outcomes between Breast Conserving Surgery Followed by Radiotherapy and Mastectomy Alone in Patients with T1-2 Stage and 1-3 Axillary Lymph Nodes in the Era of Modern Adjuvant Systemic Treatments
PURPOSE The role of postmastectomy radiotherapy in the treatment of T1-2 primary tumor with 1-3 positive lymph nodes is controversial. We compared treatment outcomes between breast conserving surgery followed by radiotherapy (BCS+RT) and total mastectomy alone (TM) in the setting of modern adjuvant systemic treatments. METHODS Patients with T1-2 primary breast cancer and 1-3 positive lymph no...
متن کاملLocoregional Recurrence Risk in Breast Cancer Patients with Estrogen Receptor Positive Tumors and Residual Nodal Disease following Neoadjuvant Chemotherapy and Mastectomy without Radiation Therapy
Among breast cancer patients treated with neoadjuvant chemotherapy (NAC) and mastectomy, locoregional recurrence (LRR) rates are unclear in women with ER+ tumors treated with adjuvant endocrine therapy without postmastectomy radiation (PMRT). To determine if PMRT is needed in these patients, we compared LRR rates of patients with ER+ tumors (treated with adjuvant endocrine therapy) with women w...
متن کامل